8
Oct
2024

Cipla Ltd

Exhibitor at CPHI Milan 2024 stand 4F11, API & stand 4F53, API
About Us

Cipla laid foundations for the Indian pharmaceutical industry back in 1935 with the vision to make India self-reliant in healthcare. Over the years Cipla has emerged as one of the most respected names not just in India but worldwide. Its state of the art R&D centre and manufacturing units has given the country and the world many firsts. Cipla has earned a name for maintaining one global standard for its products and services in over 180 countries. Cipla continues to support, improve and save millions of lives with its high-quality drugs and innovative devices.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
View company profile
Contact info
  • +91 22 2308 2891
  • Website
  • Cipla House Tower C, Peninsula Business Park, Ganapat Rao, Kadam Rd., Lower Parel, 400013, Mumbai, India
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4F11, API

Products Featured at CPHI Milan 2024

  • 4-dimethylamino-2-methyl phenyl phosphine sodium 200mg + cyanocobalamine 50mcg/ml

    Product 4-dimethylamino-2-methyl phenyl phosphine sodium 200mg + cyanocobalamine 50mcg/ml

    Cipla Ltd offers wide range of veterinary products which includes 4-dimethylamino-2-methyl phenyl phosphine sodium 200mg + cyanocobalamine 50mcg/ml. Dosage form: injection. Contact us for more information.
  • Abacavir sulfate

    Product Abacavir sulfate

    Cipla Ltd offers wide range of api which includes abacavir sulfate. It belongs to abacavir sulfate category. Contact us for more information.
  • Abacavir sulphate 20 mg/ml

    Product Abacavir sulphate 20 mg/ml

    Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 20 mg/ml. Dosage form: oral solution. Therapeutic area: hiv-aids. Packaging type: bottle. Contact us for more information.
  • Abacavir sulphate 300 mg

    Product Abacavir sulphate 300 mg

    Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 300 mg. Dosage form: tablets. Therapeutic area: hiv-aids. Packaging type: container. Contact us for more information.
  • Abacavir sulphate 60 mg

    Product Abacavir sulphate 60 mg

    Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 60 mg. Dosage form: tablets. Therapeutic area: hiv-aids. Packaging type: container. Contact us for more information.